Neuropeptide Y Protects Brain Connections in Alzheimer's Disease Through the ABCA7 Gene | Research

The takeaway

The Alzheimer's risk gene ABCA7 regulates neuropeptide Y production, which is essential for maintaining brain connections through BDNF signaling — and its loss accelerates synaptic damage.

NPY rescued synapses
ectopic neuropeptide Y restored synaptic density lost from ABCA7 deletion

What the researchers found

ABCA7 loss suppresses neuropeptide Y expression, reducing BDNF and synaptic density — a mechanism directly linking this Alzheimer's risk gene to brain resilience through NPY-BDNF-NGFR signaling.

Why it matters

This study reveals a concrete molecular pathway connecting one of the top Alzheimer's risk genes to brain protection, opening potential therapeutic targets through neuropeptide Y supplementation or pathway modulation.

The numbers in context

Used single-cell transcriptomics in heterozygous abca7+/- knockout zebrafish combined with Aβ42 toxicity models.

How the study worked

CRISPR-Cas9 knockout zebrafish with single-cell transcriptomics, human iPSC-derived neurons exposed to Aβ42, and clinical correlation with human AD brain samples and genetic data.

Who was studied

CRISPR ABCA7 knockout zebrafish with amyloid-beta exposure

What this study cannot tell us

Zebrafish and iPSC-derived neuron models may not fully recapitulate human Alzheimer's pathology; clinical correlations are observational; causal pathway in humans not yet proven through intervention studies; NPY supplementation as therapy not tested.

How to read the evidence

Preliminary but multi-level evidence spanning zebrafish models, human iPSC neurons, and clinical AD patient data, providing convergent support for the proposed mechanism.

When this study was published

Published in 2024, representing current advances in understanding Alzheimer's genetic risk mechanisms.

The bigger picture

Understanding how genetic risk factors actually cause Alzheimer's at the molecular level is crucial for developing targeted therapies. This study suggests that boosting neuropeptide Y signaling could help maintain brain resilience in people with ABCA7 risk variants.

Questions still open

Could intranasal or targeted NPY delivery prevent or slow synaptic loss in early Alzheimer's?
Are ABCA7 variant carriers specifically responsive to NPY-boosting interventions?
Does this ABCA7-NPY pathway interact with other known Alzheimer's risk pathways like APOE?

Common questions

What does neuropeptide Y have to do with Alzheimer's disease?

NPY helps maintain healthy connections between brain cells. This study found that when the ABCA7 gene (a known Alzheimer's risk gene) is impaired, NPY production drops, leading to loss of brain connections. NPY levels also decline as Alzheimer's progresses in patients.

Could boosting neuropeptide Y prevent Alzheimer's?

It's too early to say, but the study showed that adding NPY back to brain cells with ABCA7 problems restored their synaptic connections. This suggests NPY-boosting strategies could be worth testing in future Alzheimer's prevention trials.

Read the original research

ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.

Cell genomics, 4(9), 100642

View on PubMed ↗Publisher’s paper ↗

Citation

Tayran, Hüseyin; Yilmaz, Elanur; Bhattarai, Prabesh; Min, Yuhao; Wang, Xue; Ma, Yiyi; Wang, Ni; Jeong, Inyoung; Nelson, Nastasia; Kassara, Nada; Cosacak, Mehmet Ilyas; Dogru, Ruya Merve; Reyes-Dumeyer, Dolly; Stenersen, Jakob Mørkved; Reddy, Joseph S; Qiao, Min; Flaherty, Delaney; Gunasekaran, Tamil Iniyan; Yang, Zikun; Jurisch-Yaksi, Nathalie; Teich, Andrew F; Kanekiyo, Takahisa; Tosto, Giuseppe; Vardarajan, Badri N; İş, Özkan; Ertekin-Taner, Nilüfer; Mayeux, Richard; Kizil, Caghan. (2024). ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling.. Cell genomics, 4(9), 100642. https://doi.org/10.1016/j.xgen.2024.100642